HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yusuke Nakamura Selected Research

Esophageal Neoplasms (Esophageal Cancer)

1/2022Phase II Adjuvant Cancer-specific Vaccine Therapy for Esophageal Cancer Patients Curatively Resected After Preoperative Therapy With Pathologically Positive Nodes; Possible Significance of Tumor Immune Microenvironment in its Clinical Effects.
2/2018Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells.
4/2014Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients.
10/2012Identification of a novel oncogene, MMS22L, involved in lung and esophageal carcinogenesis.
7/2012Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.
3/2012Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.
6/2011Retraction. Cloning and expression of soluble recombinant human esophageal cancer-related gene 4 protein and its inhibitory effect on tumor growth in vitro and in vivo in esophageal carcinoma.
7/2010Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.
1/2010Activation of WD repeat and high-mobility group box DNA binding protein 1 in pulmonary and esophageal carcinogenesis.
8/2009Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yusuke Nakamura Research Topics

Disease

314Neoplasms (Cancer)
03/2024 - 01/2002
82Carcinogenesis
11/2020 - 08/2002
70Breast Neoplasms (Breast Cancer)
05/2022 - 01/2002
51Lung Neoplasms (Lung Cancer)
01/2022 - 04/2003
34Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 03/2002
24Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 03/2004
22Testicular Neoplasms (Testicular Cancer)
05/2017 - 08/2004
20Prostatic Neoplasms (Prostate Cancer)
03/2024 - 12/2003
18Urinary Bladder Neoplasms (Bladder Cancer)
11/2018 - 04/2005
17Asthma (Bronchial Asthma)
09/2023 - 06/2005
17Stomach Neoplasms (Stomach Cancer)
05/2023 - 12/2002
17Carcinoma (Carcinomatosis)
07/2022 - 08/2002
17Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 07/2003
17Adenocarcinoma
12/2017 - 06/2002
15Neoplasm Metastasis (Metastasis)
05/2023 - 02/2004
15Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 10/2004
15Infections
01/2013 - 05/2003
14Hepatocellular Carcinoma (Hepatoma)
11/2023 - 06/2002
14Squamous Cell Carcinoma of Head and Neck
01/2023 - 01/2015
14Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 06/2005
14Chronic Hepatitis C
05/2013 - 05/2009
13Rheumatoid Arthritis
07/2013 - 08/2003
12Ovarian Neoplasms (Ovarian Cancer)
07/2021 - 11/2007
11Colonic Neoplasms (Colon Cancer)
06/2020 - 03/2002
11Drug-Related Side Effects and Adverse Reactions
03/2012 - 01/2005
10Synovial Sarcoma (Synovioma)
10/2023 - 10/2002
10Adenocarcinoma of Lung
03/2019 - 06/2002
9Leukemia
03/2024 - 04/2003
9Hypoxia (Hypoxemia)
08/2023 - 06/2005
9Inflammation (Inflammations)
01/2019 - 12/2003
9Obesity
11/2010 - 01/2004
8Residual Neoplasm
01/2022 - 04/2014
7Type 2 Diabetes Mellitus (MODY)
07/2013 - 01/2005
7Disease Susceptibility (Diathesis)
01/2013 - 01/2002
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2024 - 08/2002
6Anemia
08/2023 - 10/2010
6Fibrosis (Cirrhosis)
01/2023 - 09/2010
6Melanoma (Melanoma, Malignant)
12/2021 - 12/2004

Drug/Important Bio-Agent (IBA)

120Proteins (Proteins, Gene)FDA Link
05/2022 - 10/2002
112Complementary DNA (cDNA)IBA
01/2015 - 01/2002
69Peptides (Polypeptides)IBA
11/2023 - 12/2002
59Small Interfering RNA (siRNA)IBA
02/2020 - 05/2004
58AntigensIBA
03/2023 - 08/2004
50Biomarkers (Surrogate Marker)IBA
09/2022 - 08/2006
27DNA (Deoxyribonucleic Acid)IBA
09/2022 - 01/2002
25EpitopesIBA
08/2021 - 01/2004
24T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2024 - 12/2004
23Messenger RNA (mRNA)IBA
11/2020 - 01/2002
22Phosphotransferases (Kinase)IBA
09/2021 - 04/2005
21EnzymesIBA
12/2020 - 08/2003
19HLA-A Antigens (HLA-A)IBA
05/2018 - 12/2004
18Protein Subunit VaccinesIBA
11/2023 - 11/2008
18InterferonsIBA
01/2023 - 05/2009
18TamoxifenFDA LinkGeneric
01/2019 - 01/2007
17Cancer VaccinesIBA
01/2022 - 05/2006
16VaccinesIBA
03/2023 - 11/2008
16Tumor Biomarkers (Tumor Markers)IBA
05/2022 - 08/2002
16Protein Kinases (Protein Kinase)IBA
12/2021 - 09/2003
16Histones (Histone)IBA
10/2020 - 10/2004
13Carrier Proteins (Binding Protein)IBA
02/2020 - 01/2005
12HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 02/2009
12Lysine (L-Lysine)FDA Link
10/2020 - 02/2011
11CytokinesIBA
01/2023 - 12/2003
11Circulating Tumor DNAIBA
09/2022 - 07/2019
11Immune Checkpoint InhibitorsIBA
07/2022 - 01/2016
11Estrogen ReceptorsIBA
05/2022 - 10/2004
11Hormones (Hormone)IBA
04/2020 - 06/2007
11Cytochrome P-450 CYP2D6 (CYP2D6)IBA
01/2017 - 05/2008
11Histone MethyltransferasesIBA
10/2015 - 08/2004
11Ribavirin (Virazole)FDA LinkGeneric
01/2012 - 09/2010
10GemcitabineFDA Link
11/2018 - 04/2003
9beta CateninIBA
07/2010 - 01/2002
8OTS167IBA
11/2020 - 12/2014
8Transcription Factors (Transcription Factor)IBA
01/2020 - 01/2002
8Oncogene Proteins (Oncogene Protein)IBA
01/2018 - 11/2004
8Insulin-Like Growth Factor II (Somatomedin A)IBA
07/2017 - 01/2007
8Genetic Markers (Genetic Marker)IBA
02/2013 - 01/2009
7AntibodiesIBA
10/2023 - 12/2004
7RNA (Ribonucleic Acid)IBA
03/2023 - 01/2007
7Cell-Free Nucleic AcidsIBA
05/2022 - 01/2020
7Amino AcidsFDA Link
11/2019 - 05/2004
7Cadherins (E-Cadherin)IBA
01/2016 - 04/2005
7Histone DemethylasesIBA
07/2015 - 03/2010
7Indicators and Reagents (Reagents)IBA
02/2013 - 01/2002
6Docetaxel (Taxotere)FDA Link
03/2024 - 04/2003
6Hemoglobins (Hemoglobin)IBA
08/2023 - 09/2003
6Neoplasm Antigens (Tumor Antigens)IBA
07/2022 - 10/2004
6ErbB Receptors (EGF Receptor)IBA
05/2022 - 07/2003
6Estrogens (Estrogen)FDA Link
11/2020 - 08/2009
6LectinsIBA
02/2020 - 01/2005
6Glycoproteins (Glycoprotein)IBA
02/2020 - 09/2007
6OligonucleotidesIBA
01/2020 - 06/2002

Therapy/Procedure

152Therapeutics
01/2024 - 08/2002
44Immunotherapy
03/2023 - 08/2004
41Drug Therapy (Chemotherapy)
12/2023 - 01/2002
27Lasers (Laser)
11/2017 - 06/2002
9Radiotherapy
09/2021 - 07/2002
8Neoadjuvant Therapy
11/2018 - 03/2004
7Precision Medicine
09/2021 - 07/2010
6Castration
03/2024 - 05/2009